Evidence map›Paper›PMID 39679197›Full record

ArticleFrontiers in cellular and infection microbiology2024

ZIKV prM hijacks PIM1 kinase for phosphorylation to prevent ubiquitin-mediated degradation and facilitate viral replication.

Yingying Ren, Yishuo Liu, Rui Pang, Gang Xu, Yining Lei, Hang Fai Kwok, Yingliang Wu, Zhijian Cao

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingying RenState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.
Yishuo LiuState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.
Rui PangState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.
Gang XuNational "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan, Hubei, China.
Yining LeiNational "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technology, Wuhan, Hubei, China.
Hang Fai KwokDepartment of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao, Macao SAR, China.
Yingliang WuState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.
Zhijian CaoState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Viral infection usually stimulates a variety of host cell factors to modulate the life cycle of the virus. PIM1, a serine/threonine protein kinase widely involved in cell proliferation, survival, differentiation and apoptosis, was recently reported to be upregulated by Zika virus (ZIKV) infection. However, how ZIKV-PIM1 interactions affect the viral life cycle are not fully understood. Methods and results: Here, we demonstrated that ZIKV replication was suppressed by the PIM1 kinase inhibitor SGI-1776 in both Discussion: These findings revealed PIM1 as a critical host factor that is advantageous to ZIKV and revealed that targeting the PIM1‒prM axis is a conducive strategy for controlling ZIKV infection.

Indexed as

ProteolysisProto-Oncogene Proteins c-pim-1Virus ReplicationZika VirusAnimalsChlorocebus aethiopsHEK293 CellsHost-Pathogen InteractionsHumansImidazolesMicePhosphorylationPyridazinesUbiquitinUbiquitinationUbiquitin-Protein LigasesImidazolesPIM1 protein, humanPim1 protein, mouseProto-Oncogene Proteins c-pim-1PyridazinesSGI 1776UbiquitinUbiquitin-Protein LigasesphosphorylationPIM1prMubiquitinationZIKV

Identifiers

PMID39679197
PMCPMC11638163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.